Skip to main content
SpringerLink
Log in

Thrombolytics

  • Chapter
  • First Online:
Adverse Cutaneous Drug Reactions to Cardiovascular Drugs

  • 879 Accesses

Abstract

Thrombolytic (fibrinolytic) agents include alteplase (tissue plasminogen activator), anistreplase (anisoylated plasminogen streptokinase activator complex), reteplase, streptokinase, tenecteplase, and urokinase.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haire WD. Pharmacology of fibrinolysis. Chest. 1992;101:91S–7S.

    Article  CAS  PubMed  Google Scholar 

  2. Litt JZ. Drug eruption reference manual. 19th ed. Boca Raton: CRC Press (Taylor and Francis Group); 2013.

    Google Scholar 

  3. Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part III. Cardiol Rev. 2002;10:337–48.

    Article  PubMed  Google Scholar 

  4. Smithson JE, Kennedy CT, Hughes S. A new skin lesion associated with intravenous streptokinase. BMJ. 1993;306:973.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Mirowska-Guzel D, Kobayashi A, Członkowska A. Widespread subcutaneous haematoma after thrombolytic therapy in stroke patients. Mild falls at stroke onset may be dangerous. Neurol Neurochir Pol. 2006;40:536–8.

    PubMed  Google Scholar 

  6. Khanlou H, Malhotra G, Khanlou N, Eiger G, Frechie P. Massive subfascial hematoma after alteplase therapy for acute myocardial infarction. Am J Med Sci. 1999;317:53–4.

    Article  CAS  PubMed  Google Scholar 

  7. Cooper JP, Quarry DP, Beale DJ, Chappell AG. Life-threatening, localized angio-oedema associated with streptokinase. Postgrad Med J. 1994;70:592–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Cannas S, De Leo A, Marzari A. Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA). G Ital Cardiol. 1997;27:278–80.

    CAS  PubMed  Google Scholar 

  9. Massel D, Gill JB, Cairns JA. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction. Can J Cardiol. 1991;7:298–302.

    CAS  PubMed  Google Scholar 

  10. Vidovich RR, Heiselman DE, Hudock D. Treatment of urokinase-related anaphylactoid reaction with intravenous famotidine. Ann Pharmacother. 1992;26:782–3.

    CAS  PubMed  Google Scholar 

  11. Pechlaner C, Knapp E, Wiedermann CJ. Hypersensitivity reactions associated with recombinant tissue-type plasminogen activator and urokinase. Blood Coagul Fibrinolysis. 2001;12:491–4.

    Article  CAS  PubMed  Google Scholar 

  12. Zarar A, Khan AA, Adil MM, Qureshi AI. Anaphylactic shock associated with intravenous thrombolytics. Am J Emerg Med. 2014;32:113.e3–5.

    Article  Google Scholar 

  13. Ong AC, Handler CE, Walker JM. Hypersensitivity vasculitis complicating intravenous streptokinase therapy in acute myocardial infarction. Int J Cardiol. 1988;21:71–3.

    Article  CAS  PubMed  Google Scholar 

  14. Bucknall C, Darley C, Flax J, Vincent R, Chamberlain D. Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Br Heart J. 1988;59:9–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Burrows N, Jones RR. Rash after treatment with anistreplase. Br Heart J. 1990;64:289–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Gupta S, Gupta S, Thomas M, Pandey P, Aggarwal M, Mahendra A, Jindal N. Streptokinase induced purpura-like lesions. Acta Med Indones. 2012;44:69–70.

    PubMed  Google Scholar 

  17. Yerushalmi J, Zvulunov A, Halevy S. Serum sickness-like reactions. Cutis. 2002;69:395–7.

    PubMed  Google Scholar 

  18. Al-Niaimi F. Drug eruptions in dermatology. Expert Rev Dermatol. 2011;6:273–86.

    Article  Google Scholar 

  19. Schweitzer DH, van der Wall EE, Bosker HA, Scheffer E, Macfarlane JD. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction. Cardiology. 1991;78:68–71.

    Article  CAS  PubMed  Google Scholar 

  20. Creamer JD, McGrath JA, Webb-Peploe M, Smith NP. Serum sickness-like illness following streptokinase therapy. A case report. Clin Exp Dermatol. 1995;20:468–70.

    Article  CAS  PubMed  Google Scholar 

  21. Clesham GJ, Terry HJ, Jalihal S, Toghill PJ. Serum sickness and purpura following intravenous streptokinase. J R Soc Med. 1992;85:638–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  22. Davies KA, Mathieson P, Winearls CG, Rees AJ, Walport MJ. Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction. Clin Exp Immunol. 1990;80:83–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Patel A, Prussick R, Buchanan WW, Sauder DN. Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol. 1991;24:652–3.

    Article  CAS  PubMed  Google Scholar 

  24. Schwartz MW, McDonald GB. Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction. JAMA. 1987;258:1934–5.

    Article  CAS  PubMed  Google Scholar 

  25. Bucher A, Roald B. Cholesterol embolization after intravenous streptokinase therapy in acute myocardial infarction. Tidsskr Nor Laegeforen. 1993;113:1844–5.

    CAS  PubMed  Google Scholar 

  26. Arora RR, Magun AM, Grossman M, Katz J. Cholesterol embolization syndrome after intravenous tissue plasminogen activator for acute myocardial infarction. Am Heart J. 1993;126:225–8.

    Article  CAS  PubMed  Google Scholar 

  27. Pettelot G, Bracco J, Barrillon D, Baudouy M, Morand P. Images in cardiovascular medicine. Cholesterol embolization: unrecognized complication of thrombolysis. Circulation. 1998;97:1522.

    Article  CAS  PubMed  Google Scholar 

  28. Bhardwaj M, Goldweit R, Erlebacher J, Kashani M, Levin D, Leber G. Tissue plasminogen activator and cholesterol crystal embolization. Ann Intern Med. 1989;111:687–8.

    Article  CAS  PubMed  Google Scholar 

  29. Wong FK, Chan SK, Ing TS, Li CS. Acute renal failure after streptokinase therapy in a patient with acute myocardial infarction. Am J Kidney Dis. 1995;26:508–10.

    Article  CAS  PubMed  Google Scholar 

  30. Queen M, Biem HJ, Moe GW, Sugar L. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction. Am J Cardiol. 1990;65:1042–3.

    Article  CAS  PubMed  Google Scholar 

  31. Dykewicz MS, McMorrow NK, Davison R, Fintel DJ, Zull CC, Rutledge JL. Drug eruptions and isotypic antibody responses to streptokinase after infusions of anisoylated plasminogen-streptokinase complex (APSAC, anistreplase). J Allergy Clin Immunol. 1995;95:1020–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Venereology, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey

    Esen Özkaya & Kurtuluş Didem Yazganoğlu

Authors
  1. Esen Özkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurtuluş Didem Yazganoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Özkaya, E., Yazganoğlu, K.D. (2014). Thrombolytics. In: Adverse Cutaneous Drug Reactions to Cardiovascular Drugs. Springer, London. https://doi.org/10.1007/978-1-4471-6536-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6536-1_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6535-4

  • Online ISBN: 978-1-4471-6536-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation